Zacks Investment Research · TVTX · November 2, 2026Travere Therapeutics (TVTX) Reports Q3 Loss, Tops Revenue EstimatesGet the app for moreExplore stock news, insights and company research.Get the app →Source: Zacks Investment Research ↗